Stock data
Nurix Therapeutics, Inc. (NRIX)
Nurix Therapeutics, Inc. (NRIX) reported revenue of US$83.98M and net income of -US$264.46M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-11-30
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$83.98M | — | -US$285.67M | -US$264.46M | — |
| 2024 | US$54.55M | — | -US$213.03M | -US$193.57M | — |
| 2023 | US$76.99M | — | -US$155.06M | -US$143.95M | — |
| 2022 | US$38.63M | — | -US$183.87M | -US$180.36M | — |
| 2021 | US$29.75M | — | -US$117.89M | -US$117.19M | — |
Quarterly results
Data as of 2026-08-31
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-08-31 | US$673.06M | US$549.81M | — |
| 2026-05-31 | US$9.04M | -US$89.53M | — |
| 2026-02-28 | US$6.25M | -US$87.17M | — |
| 2025-11-30 | US$13.58M | -US$78.22M | — |
| 2025-08-31 | US$7.89M | -US$86.42M | — |
| 2025-05-31 | US$44.06M | -US$43.46M | — |
| 2025-02-28 | US$18.45M | -US$56.35M | — |
| 2024-11-30 | US$13.28M | -US$58.55M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.